General Atlantic L.P. Has $260.06 Million Stake in Alignment Healthcare, Inc. $ALHC

General Atlantic L.P. lowered its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 45.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 13,167,733 shares of the company’s stock after selling 11,119,494 shares during the quarter. Alignment Healthcare accounts for 9.1% of General Atlantic L.P.’s holdings, making the stock its 5th biggest position. General Atlantic L.P. owned 0.07% of Alignment Healthcare worth $260,063,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of Alignment Healthcare by 10.9% during the 4th quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock worth $305,983,000 after buying an additional 1,524,218 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of Alignment Healthcare by 167.3% during the 3rd quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock worth $193,516,000 after purchasing an additional 6,940,277 shares during the last quarter. 8 Knots Management LLC increased its stake in shares of Alignment Healthcare by 6.4% during the 2nd quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock worth $70,222,000 after purchasing an additional 300,409 shares during the last quarter. Invesco Ltd. grew its stake in Alignment Healthcare by 7.1% in the 3rd quarter. Invesco Ltd. now owns 4,466,630 shares of the company’s stock valued at $77,943,000 after buying an additional 296,101 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in Alignment Healthcare by 8.4% in the 4th quarter. Geode Capital Management LLC now owns 3,841,703 shares of the company’s stock valued at $75,884,000 after buying an additional 299,279 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Raymond James Financial set a $22.00 price objective on shares of Alignment Healthcare in a research note on Thursday, May 7th. Wolfe Research assumed coverage on shares of Alignment Healthcare in a research report on Friday, April 17th. They set an “outperform” rating and a $24.00 price target for the company. Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Zacks Research upgraded shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, April 28th. Finally, Barclays reduced their price target on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $24.30.

Alignment Healthcare Trading Up 4.1%

Shares of ALHC opened at $20.60 on Wednesday. The stock has a market capitalization of $4.26 billion, a P/E ratio of 228.89, a PEG ratio of 2.67 and a beta of 1.14. Alignment Healthcare, Inc. has a twelve month low of $11.63 and a twelve month high of $23.87. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 1.56. The firm has a fifty day simple moving average of $18.59 and a two-hundred day simple moving average of $19.43.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.04. The firm had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The company’s revenue for the quarter was up 33.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.05) earnings per share. On average, research analysts anticipate that Alignment Healthcare, Inc. will post 0.2 EPS for the current year.

Insider Activity

In other news, President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $16.09, for a total transaction of $482,700.00. Following the completion of the transaction, the president directly owned 998,813 shares of the company’s stock, valued at approximately $16,070,901.17. This represents a 2.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Hyong Kim sold 35,951 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $19.86, for a total transaction of $713,986.86. Following the transaction, the insider directly owned 331,750 shares of the company’s stock, valued at approximately $6,588,555. This trade represents a 9.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,428,666 shares of company stock valued at $27,752,485. Insiders own 5.20% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.